12:00 AM
 | 
Mar 19, 2012
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Almirall, GW Pharma sales and marketing update

Almirall and GW added Mexico to a 2005 deal granting Almirall exclusive marketing rights to Sativex in the EU, excluding the U.K. GW will receive a milestone payment...

Read the full 129 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >